A new clinical decision support tool for primary care providers (PCPs) led to a modest improvement in reinitiation of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers ...

For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...

Recommendations include use of ACE-I or ARB to slow CKD progression in patients with hypertension and albuminuria. (HealthDay News) — In a clinical practice guideline (CPG) issued by the U.S.

Chronic kidney disease (CKD) is a public health challenge that affects more than 800 million people worldwide. 1 CKD can be caused by a variety of disease processes. Many causes are difficult to ...